Por favor, use este identificador para citar o enlazar este ítem: http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/2186
Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir
Wanchao Yin.
Chunyou Mao.
Xiaodong Luan.
Dan-Dan Shen.
Qingya Shen.
Haixia Su.
Xiaoxi Wang.
Fulai Zhou.
Wenfeng Zhao.
Minqi Gao.
Shenghai Chang.
Yuan-Chao Xie.
Guanghui Tian.
He-Wei Jiang.
Sheng-Ce Tao.
Jingshan Shen.
Yi Jiang.
Hualiang Jiang.
Yechun Xu.
Shuyang Zhang.
Yan Zhang.
H. Eric Xu.
Acceso Abierto
Atribución-NoComercial-SinDerivadas
10.1101/2020.04.08.032763
The pandemic of Corona Virus Disease 2019 (COVID-19) caused by SARS-CoV-2 has become a global crisis. The replication of SARS-CoV-2 requires the viral RNA-dependent RNA polymerase (RdRp), a direct target of the antiviral drug, Remdesivir. Here we report the structure of the SARS-CoV-2 RdRp either in the apo form or in complex with a 50-base template-primer RNA and Remdesivir at a resolution range of 2.5-2.8 [A]. The complex structure reveals that the partial double-stranded RNA template is inserted into the central channel of the RdRp where Remdesivir is incorporated into the first replicated base pair and terminates the chain elongation. Our structures provide critical insights into the working mechanism of viral RNA replication and a rational template for drug design to combat the viral infection.
www.biorxiv.org
2020
Artículo
https://www.biorxiv.org/content/10.1101/2020.04.08.032763v2.full.pdf
Inglés
VIRUS RESPIRATORIOS
Aparece en las colecciones: Artículos científicos

Cargar archivos:


Fichero Tamaño Formato  
1101238.pdf3.8 MBAdobe PDFVisualizar/Abrir